<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 25 Feb 2026 16:15:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>Nanobiotix S.A (NBTX) PT Raised to $26 at Guggenheim</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Nanobiotix+S.A+%28NBTX%29+PT+Raised+to+%2426+at+Guggenheim/25957983.html</link>
   <description>Guggenheim analyst Michael Schmidt raised the price target on Nanobiotix S.A (NASDAQ: NBTX) to $26.00  (from $8.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Nanobiotix+S.A+%28NBTX%29+PT+Raised+to+%2426+at+Guggenheim/25957983.html</guid>
   <pubDate>Fri, 06 Feb 2026 07:28:22 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	  </item>
  <item>
   <title>TD Cowen Starts Nanobiotix S.A (NBTX) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/TD+Cowen+Starts+Nanobiotix+S.A+%28NBTX%29+at+Buy/25957131.html</link>
   <description>&lt;p&gt;TD Cowen analyst Tara Bancroft initiates coverage on Nanobiotix S.A (NASDAQ: NBTX) with a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;Nanobiotix’s physics-based platform technologies have broad applicability free of biological constraints. NBTXR3 amplifies radiotherapy, doubling historical survival in LA-HNSCC. The J&amp;J-led Phase III should be equally impressive, as should LA-NSCLC, supporting ~$1B of royalty revenue. We view plenty of future upside from &gt;4 more tumor types and the Curadigm and OOcuity platforms. Init. at Buy.&quot;&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on Nanobiotix S.A &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=NBTX&quot;&gt;click here&lt;/a&gt;. For more ratings news on Nanobiotix S.A &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=NBTX&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Shares of Nanobiotix S.A closed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/TD+Cowen+Starts+Nanobiotix+S.A+%28NBTX%29+at+Buy/25957131.html</guid>
   <pubDate>Fri, 06 Feb 2026 05:33:54 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	  </item>
  <item>
   <title>TD Cowen Starts Nanobiotix S.A (NBTX) at Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/TD+Cowen+Starts+Nanobiotix+S.A+%28NBTX%29+at+Buy/25957131.html</link>
   <description>&lt;p&gt;TD Cowen analyst Tara Bancroft initiates coverage on Nanobiotix S.A (NASDAQ: NBTX) with a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;Nanobiotix’s physics-based platform technologies have broad applicability free of biological constraints. NBTXR3 amplifies radiotherapy, doubling historical survival in LA-HNSCC. The J&amp;J-led Phase III should be equally impressive, as should LA-NSCLC, supporting ~$1B of royalty revenue. We view plenty of future upside from &gt;4 more tumor types and the Curadigm and OOcuity platforms. Init. at Buy.&quot;&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on Nanobiotix S.A &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=NBTX&quot;&gt;click here&lt;/a&gt;. For more ratings news on Nanobiotix S.A &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=NBTX&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Shares of Nanobiotix S.A closed</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/TD+Cowen+Starts+Nanobiotix+S.A+%28NBTX%29+at+Buy/25957131.html</guid>
   <pubDate>Fri, 06 Feb 2026 05:33:54 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</link>
   <description>si-local-file:///var/storage/secattach/20251201/25683528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</guid>
   <pubDate>Mon, 01 Dec 2025 16:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</link>
   <description>si-local-file:///var/storage/secattach/20251201/25683528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</guid>
   <pubDate>Mon, 01 Dec 2025 16:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</link>
   <description>si-local-file:///var/storage/secattach/20251201/25683528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</guid>
   <pubDate>Mon, 01 Dec 2025 16:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
 </channel>
</rss>
